Entities

Kojo provides procurement, inventory, and materials-management software for construction contractors.

Lacework developed a cloud-security platform for detecting threats, vulnerabilities, and misconfigurations across cloud environments; Fortinet acquired the company in 2024.

Lean Technologies provides open-banking infrastructure that lets businesses connect to bank accounts, initiate payments, and access financial data across the Middle East.

Local Kitchens operates a multi-brand restaurant platform that prepares food from partner restaurants for pickup and delivery in neighborhood locations.

Lookout Ventures is a seed-stage venture capital platform backing B2B software companies in overlooked US geographies, helping founders develop from seed to Series A and beyond. Its investment interests include cloud infrastructure, cybersecurity, developer tools, managed-service-provider software and vertical SaaS, including AI-enabled enterprise applications. Its current own directory publishes general partners Matt Bressler and Will Rayner, chairman Jim Pastoriza and six operating partners supporting product, engineering, sales, customer success and technology operations. It is distinct from the cybersecurity company Lookout. The exact fund is Lookout Ventures I LP, Delaware, SEC private-fund identifier805-6421238825 and CIK2010459; its GP is Lookout Ventures I GP LLC. Primary fund filings identify managing members Matthew Bressler, William Rayner and James J. Pastoriza, bridging the published Matt, Will and Jim aliases. Communication Capital Partners LLC, the TDF Ventures adviser CRD162954, identifies this GP and fund in its March2026 FormADV. This documents an affiliated advisory and legal structure, not a merger of Lookout and TDF or reassignment of TDF historical company investments. The founders describe continuity with their prior TDF work and access to its operating-partner network. The February21,2025 amended FormD reports USD28,050,000 in actual sold subscriptions toward a USD30,000,000 offering target, with first sale February23,2024. This is a cumulative completed-subscription disclosure, not proof of a final USD30M fund close, company financing or assets under management. The fund was formed in2023. Its underlying portfolio tickets and exact subscribing vehicles remain undisclosed unless a company financing explicitly identifies them. Circuitry.ai’s October1,2025 issuer announcement identifies Lookout as a participant in its closed seed financing, with total and ticket amounts undisclosed. The retained Arpio investment is preserved; its legacy USD15M row links an USD8.2M issuer financing source, so the differing scope remains an explicit audit gap rather than a guessed correction. The current Companies page includes portfolio and prior investment experience associated with the team’s TDF history; older company cards alone do not prove new capital from Lookout’s2023 fund. No neuroscience specialization is claimed. The current investment leaders’ own illustrated avatars have been rejected as authentic portraits. Genuine caption-bound original photographs from affiliated TDF’s own directory are used; the six operating partners have genuine smaller native published photographic portraits. Hidden older sections and placeholder design rows are excluded from the current nine-person roster.

Makes portable infrared devices for identifying plastics and textiles.

Maybern provides fund-administration and accounting software for private-capital managers.

Medra develops AI-enabled robotic laboratory systems for automating biological experiments and life-sciences research workflows.

Consumer-electronics company designing premium hardware and publishing new games for original retro-game cartridges, including the Chromatic handheld and M64 console.

Financial-data infrastructure company helping lenders use cross-border credit histories, cash-flow data and income verification in underwriting.

Cloud observability company that stores telemetry in an open data lake and uses a knowledge graph and AI workflows to investigate application and infrastructure incidents.

Designs superconducting quantum processors with error protection in hardware.

Ground State Ventures, formerly QDNL Participations, is an early-stage venture capital firm specializing in quantum technology. It backs companies building quantum computing hardware and software, sensing, communications and infrastructure, including quantum technologies applied to AI, drug discovery and industrial systems. The firm invests from the beginning of a company’s development and provides technical diligence, company-building support, board involvement and follow-on capital. It began with a focus on the Dutch quantum ecosystem and has expanded internationally, with published offices in Amsterdam, London and San Francisco. Its named portfolio spans quantum processors and controls, quantum networking, nanodiamond sensing for cellular research and quantum-accelerated AI infrastructure. Ground State announced its rebrand in April 2026 alongside an update that its global quantum fund had raised $88 million and was approaching final close. Its own legal disclosure identifies QDNLP Fund Management B.V. as GSV Fund Management.

Quake Capital is a US early-stage venture investment manager whose published portfolio spans software, AI-enabled products, industrial automation, healthcare, neurotechnology and climate/impact ventures. Its current website describes first-investment stages including pre-seed, seed and Series A. Portfolio-stage tags describe the first investment, not current company maturity or an exact cash closing date. The manager supports founders through operating and venture-development experience. The exact SEC-reporting legal adviser is Quake Investment Strategies, LLC, doing business as Quake Capital, CRD290746 and exempt-reporting file802-112305. Its30March2026 Form ADV identifies an Austin, Texas principal office and eight private fund vehicles. Exempt reporting is distinct from SEC adviser registration. The institution is unrelated to earthquake-monitoring businesses, Quake gaming and similarly named investment companies. The current primary public leadership roster names Founder and General Partner Glenn Argenbright, Managing Partner Jason Fernandez, and Climate & Impact Managing Partners Parul Madan and Nikhil Madan. Jason R. Fernandez also signed the March2026 adviser filing as Chief Compliance Officer. Their career startup, IPO and exit totals are individual/team background claims, not this manager’s current portfolio count, returns or cash invested. Earlier founding activity and a2017 formal launch appear in public histories; no exact incorporation day is inferred. The legal portfolio includes Quake Seed Capital Fund and its II/III vehicles, Quake High Confidence Fund and its II/III/III-Alpha vehicles, and Quake5G Seed FundI. Fund asset values reported in Form ADV are filing snapshots rather than fund closes. The5G vehicle’s2June2025 FormD reports USD228,000 of fund interests sold from a USD1million offering, with first sale12April2021; the target is not a verified USD1million raise, and interests sold are not LP drawdowns. Other fund cash close amounts remain undisclosed in the reviewed primary evidence. Neurosity’s own issuer fundraising page identifies Quake Capital as a backer, corroborated by the manager’s public portfolio identity; its specific stage, date, check size and subscriber vehicle are undisclosed. Existing company checks and personal/private provenance are preserved. Public WordPress portfolio records include133 named published entries; exact-domain and investment-status verification is required before each additional company link.

Digital real-estate closing platform providing a shared system of record for title and escrow agents, lenders, real-estate professionals and homebuyers.

Builds diamond-based quantum computing and sensing chips operating at room temperature.

Builds photonic random-number generators and hardware for probabilistic computing.

Builds causal AI software for modelling and simulating business decisions.

Social gaming platform where friends use voice chat and play multiplayer mobile and web games, with tools for developers to build and publish games using AI.

Develops tin-oxide inks for manufacturing durable perovskite solar cells.

Spacecadet Ventures is an early-stage investment platform combining pre-seed and seed capital with brand strategy, storytelling and marketing support. It calls itself The Marketing VC and backs frontier technologies in AI, biotechnology, aerospace, robotics and energy. Its own mission page describes typical USD100,000–500,000 investments; this range is not a known ticket in every portfolio company. Published core founders are Wisam Faiz Abdulla, known as Wiz, co-founder and general partner, and Daniel Gus Eckler, co-founder and chief marketing officer. A related creative studio supplies strategy, design and marketing services; the studio’s broader community and clients are not automatically venture-fund employees or investments. The exact legal adviser is Spacecadet Ventures LLC, CRD316985 and SEC exempt-reporting file802-135996, directly confirmed by its March26,2026 FormADV. Wisam Faiz Abdulla and Daniel Gus Eckler are its two listed managers, with August2021 status (month only). Its mission’s collective agreement separately names Space Cadet Expeditions LLC for carry distributions. AngelList-administered LP series and separate advisory/administrative entities remain legally distinct; no invented legal merger or personal investor allocation is asserted. An unrelated Raleigh AI product studio at spacecadet.io is not this venture platform. The current adviser filing identifies43 actual legal LP series, often with AngelList Advisors furnishing the detailed fund reporting. All unverified actual closing amounts and precise close dates remain unknown. A historical own fund landing page advertises a USD15M pre/seed fund; the founder’s contemporaneous post says the last USD500,000 remained open while the fund was oversubscribed. This describes fund marketing and closing in progress, not evidence of a final completed USD15M cash close. The company’s newer USD75M AUM statement is asset-management scale, not a fund raise. The published portfolio includes Modulo Bio’s neuroimmune discovery platform, Prophetic’s lucid-dream technology, Psyrin’s AI-assisted serious-mental-illness diagnostics, Function Health, Parallel Bio, Loyal, biotechnology companies and AI software, aerospace and robotics businesses. Portfolio cards establish source-qualified affiliations but do not disclose a specific subscribing vehicle or funding round. Its public Crew page separately labels investor/backer supporters including Marc Andreessen, Chris Dixon, Alexis Ohanian, Stewart Butterfield, Semil Shah, Hunter Walk, Roger Ehrenberg, Ben Ling, James Currier, Andy Weissman and Andrew D’Souza, plus Gradient Ventures and Bain Capital; these are not presented as operating team members or source-proven corporate treasury checks. The manager’s currently published founder pictures are illustrated astronaut avatars and have been rejected as authentic headshots. Genuine name-bound original professional portraits are used instead. Exact current wider investment-team roster, private subscribing series for historical company checks and completed fund-close details remain qualified public-source gaps.

Voice-AI productivity platform offering text-to-speech, voice typing, AI note-taking, document assistance and voice infrastructure across web, desktop and mobile apps.

1047 Games is the independent game studio behind Splitgate, a free-to-play multiplayer first-person shooter built around portal-based combat.

Studio is an online education platform offering project-based creative courses and personalized coaching experiences from expert instructors.

Sway Capital is a multi-strategy alternative-investment platform based in Newport Beach, California, co-founded by Brian Nugent and Bill Malloy. Its platforms include private equity and venture capital, impact investing, media and institutional alternatives. Sway Ventures is its venture-capital platform, backing technology companies from seed through growth, including AI software and healthcare technology. The current parent directory lists 28 operating, investment and administrative team members plus seven platform advisers. Six starred staff are engaged through an outsourced shared-services provider rather than assumed employees. The historical MedCrypt investment imported under the Sway Capital parent name remains on this profile. Verified Affinity CRM investments are represented under the dedicated Sway Ventures platform; an unsupported duplicate Affinity participation was removed while raw source provenance was retained.

Syntiant develops low-power AI chips, sensors and machine learning software for devices. Its Neural Decision Processors enable local processing of speech, sound and other sensor data without relying on continuous cloud computing.

Trackonomy combines connected hardware, sensors, and software to provide item-level visibility and operational intelligence across physical supply chains.

Transcarent provides employers and health-plan members a single platform for medical, pharmacy, surgery, mental-health, and navigation services.

Research university. University identity is distinct from any separately managed venture fund or investment arm.

Develops generators that harvest energy from ocean and vessel motion.

Vulpes Investment Management is a Singapore-based alternative investment manager backed by family-office capital, with principals investing alongside outside co-investors. Its current legal Singapore entity is Vulpes Investment Management Private Limited, identified in the March 30, 2026 SEC Form ADV under CRD161048 and in the Monetary Authority of Singapore directory as a licensed fund manager at 21 Merchant Road, #02-01, Singapore058267. Its independent UK operating company has separately named leadership. Strategies span life sciences, venture capital, AI-supported tail-risk and long-short equities through VaiL/S TR, fundamental equities, agriculture and German residential real estate. The Life Sciences strategy seeks undervalued UK biotechnology and medical-device businesses and takes a hands-on, long-term approach; published portfolio history includes Scancell, Oxford Biomedica, Proteome Sciences, Oxford Endovascular, Chronos Therapeutics, Sibelius and Oxford Biometrics. This portfolio supports relevance to deep technology, neurological-device research and biotechnology without implying approval of investigational products. Vulpes Ventures is the venture platform launched from the manager and is distinguished from a separate legal manager or unverified fund vehicle. The current website publishes nineteen operating and investment people and seven senior advisors or non-executive directory members; the current regulator additionally identifies Wilson Er as Singapore Chief Investment Officer. Singapore regulator titles for Chee Seng Ng differ from the own-site operations title, and UK CEO Stephen Diggle and UK chairman Martin Diggle are qualified to their entity. Stephen founded Vulpes following Artradis closure; Artradis historical assets, trading profits and seed capital are not Vulpes fund raises. Publicly named strategies and funds are recorded with undisclosed capital and dates unless actual subscriptions or a closing is supported by primary evidence.

Wildlife Studios develops and publishes mobile games including Zooba, Tennis Clash, Sniper 3D, and War Machines.

Develops photonic radar for vehicle autonomy and infrastructure sensing.

Yendo offers vehicle-secured credit cards and is expanding toward an AI-powered digital bank for consumers underserved by traditional lenders.

Zelos is a volunteer coordination platform that provides shift scheduling, task dispatch, and communication tools for teams and communities.

An early-stage venture firm investing in technologies for physical infrastructure, including energy, power, mobility, logistics, digital networks, water, waste and biomanufacturing. It backs software, AI, robotics and infrastructure projects that modernize these essential systems.

Investment manager whose opportunity fund focuses on specialty credit investments in technology-enabled companies.

Blue Heron Capital is a Richmond, Virginia growth equity firm focused on healthcare and enterprise technology. It invests in companies entering commercial growth and combines financial capital with operating advice from its OA Collaborative network. The firm's portfolio spans healthcare AI, diagnostics, virtual care and enterprise software, including Ognomy Sleep, Insightin Health, VIDA Diagnostics and Tava Health. Its public staff directory lists Co-Founders and Managing Partners Tom Benedetti and Andrew Tichenor, Operating Partner Jim Riley, Controller Christine Lane, Vice President Kevin Musco, Accounting Manager Laura Tizard, Principal Nick Graziano and Director of Investor Relations Matt Jacobson. OA Collaborative members are outside operators and advisers with separate affiliations. Blue Heron publicly reported raising $102 million for Fund III and participated in Ognomy Sleep's $20 million Series A announced June 30, 2026.

Coinvest Capital is a sovereign evergreen venture investor owned by Lithuania’s national development bank ILTE and funded by Lithuanian and European Union public capital. It co-invests with business angels and other venture funds in European startups that create value for Lithuania. Its strategy supports research-intensive companies in life sciences, medical technology, artificial intelligence, deep technology, climate and energy, space, aviation and defence. It invests through equal-term co-investments and a profit-sharing model that can allocate additional exit returns to accredited private co-investors.

Corazon Capital is an early-stage venture capital firm investing nationally in technology companies, with investors in Chicago, Los Angeles, San Francisco and New York. It backs pre-seed, Seed and Series A founders across consumer products, enterprise software, marketplaces, commerce infrastructure and health and wellness. Its Fund IV emphasizes AI-native companies that change how people learn, connect, transact, work and live. Founded by experienced consumer-internet operators Sam Yagan and Steve Farsht, the firm combines capital with practical help on product-market fit, growth, marketing and company building. Published investments span speech AI, AI-assisted business tools, industrial manufacturing software and digital health as well as consumer platforms. The legal operator and registered investment adviser is Corazon Group LLC; its fund-specific general partners and limited partnerships are separate legal vehicles.

Firestreak Ventures is Walter Kortschak’s early-stage investment platform, writing first checks into AI-native companies and supporting founders over long holding periods. Its official website emphasizes pre-seed investing, rapid decisions, product and go-to-market guidance, talent and fundraising support, and patient capital without a fund-driven liquidity clock. The founder’s own professional biography filed as an SEC exhibit describes his transition to investing his own capital through Firestreak; a closed outside-LP fund, fund size and precise underlying legal investment vehicle are not publicly established in the reviewed sources. The current website names Walter Kortschak as founder, while an April2026 primary interview and Daytona’s own contributor biography identify Amir Rustamzadeh as a partner. Its current portfolio section includes Hugging Face, Perplexity, Cohere, Lovable, Etched, Groq, Modal, Athena, Owner, Filigran, Oleria, Skyflow, Motherduck, Aaru and Polymarket. A separate founder track-record section lists earlier or growth investments and is not treated as proof that Firestreak made those corporate investments. The firm explicitly disclaims affiliation with SignalFire Management Services LLC and SignalFire LLC; Kortschak’s separate growth-investment platform Kortschak Investments is not merged into Firestreak.

Founder-backed investment fund associated with Steven Bartlett's FlightStory, investing across technology, health, biotech, commerce and space.

GreyMatter Capital is a U.S. venture firm focused on mental and brain health, behavioral care and emotional wellbeing. Founded by Danish Munir and Andrew Barr, it backs technology-enabled care businesses and frontier approaches to neurological disorders, neuromodulation and healthcare AI. Its published portfolio includes Blackbird Health, Applied Cognition, NeuroBionics and ReflexAI. The firm supports founders with scientific and clinical networks, recruiting, customer introductions and operational guidance. SEC issuer filings identify GreyMatter BrainTrust LLC as management company and separate GreyMatter GP I LLC and GP II LLC partnerships; headquarters filings place these vehicles in Berkeley, California. This mental-health manager is distinct from the greymatter.capital blockchain research publication and greymatter.gg gaming firm. Published fund subscriptions are qualified as reported securities sold, rather than final closing amounts or assets under management.

MTech Capital is an insurance and financial-technology venture investment firm co-founded by Brian McLoughlin and Kevin McLoughlin in2018 according to its current published biographies. Its own site identifies MTech Capital Management LLC; SEC IAPD CRD288626/802-130644 identifies the same US manager as an active exempt reporting adviser, not a registered investment adviser. The active London affiliate MTech Capital Management(UK)LLP, OC424493, was incorporated October16,2018. This retained investment-firm profile covers the MTech brand and manager, separate from unrelated MTech industrial and listed technology companies. MTech focuses on the application of AI to improve customer experience and employee productivity across insurance and financial services, investing mainly at early stage in North America and Europe with exceptions for growth opportunities. Its published areas include insurance, asset management, health and wellness, employee benefits, retirement savings and enterprise software. Its own portfolio identifies insurance risk/pricing and documentAI, healthcare benefits verification/prior authorization, dental revenue-cycle automation and computer-vision workplace safety. These are manager-described products and relationships, not independent clinical or performance validation. The current directory names five operating people: Brian and Kevin McLoughlin, principals Nick Bendell and Jack Prescott, and office administrator Taylor De Bruin. Portfolio company leaders in testimonials, investor-network representatives and external mentors are not inferred employees or personal cash investors. The manager’s July10,2018 original BusinessWire release reports a USD75M initial close in capital commitments from three anchor investors including CNA and NNGroup, across parallel US and Luxembourg limited partnerships. A USD150M objective was a target, not a completed close. The current own LP portal separately lists FundI and FundII; CNMV confirms the Luxembourg FundII(EU)SCSp vehicle and its distinct external AIFM JTCGlobalAIFMSolutionsSA. Legal feeder/parallel registration is not an additional cash raise. No independently verified FundII cash closing amount or exact close day is asserted, and USD0 in a2024 secondary-hosted FormD is not a perpetual no-investment conclusion.

Myelin VC is a founder-led venture-capital firm established in2019, with a publicly listed Madrid headquarters and Buenos Aires presence. Its own mandate is industry-agnostic investing from seed through Series A. The current published team has eight investment and operations professionals, including a specifically non-executive general partner. Its portfolio establishes AI, neurotechnology, space, computing, robotics and biotechnology activity: examples include Neurosity’s brain-sensing wearable, Efficient’s computing hardware, Modern Intelligence’s defense AI, Outpost’s spacecraft, and reproductive/clinical technology businesses. The relevance comes from the published investments, rather than the neurological meaning of the firm’s name. Native SEC disclosures connect legal vehicles to general partner Myelin II Management LLC and executive/signatory Matias Alan Nisenson. Documented vehicles are Myelin II Limited Partnership, Myelin II SPV I Limited Partnership and Myelin Deep Tech Limited Partnership, incorporated in British Columbia; their US-dollar securities-sales snapshots are distinct from final fund closes, assets under management and company check allocations. Fourier Health’s issuer identifies Myelin as prior pre-seed backing, separate from its later8.4M seed financing; that issuer’s owner maintains the transaction. This retained manager is distinct from Myelin Foundry, the myelin.ai lab, myelin.com immersive-therapy business and unrelated research collectives.

Barcelona venture capital firm investing at the intersection of healthcare and information technology. It backs pre-seed through seed-stage medical devices and tools for healthcare organizations across Europe, North America, Israel and Australia, with an emphasis on data, computing and founders addressing unmet clinical needs.

Northern Gritstone is an independent investment company backing science-based businesses in Northern England, particularly university spinouts and other companies commercialising defensible intellectual property. It invests in life sciences and deep technology, including AI, semiconductors, advanced materials and health technologies, and supports companies from their first commercial steps through later growth. Its Northern Arc relationships span Leeds, Liverpool, Manchester and Sheffield. NG Innovation Services supplies company-building support in talent, growth, co-investment and business services. Northern Gritstone Limited (company 12982592) holds permanent capital; its wholly owned Northern Gritstone Investment Manager Limited (15186303, FCA FRN 1007673) is the regulated investment-management subsidiary.

Portland Seed Fund is a Pacific Northwest venture capital manager founded in 2011 by Angela Jackson and Jim Huston. It invests at pre-seed and seed stage in capital-efficient technology businesses and reports over 200 investments and $45 million managed across five funds. Its deep-tech sister vehicle, Intrepid Oregon Fund, supports Oregon science and technology startups in bioscience, medical devices, climate technology, advanced materials and manufacturing. The current firm directory lists Angela Jackson, Jenn Lynch and Steve Eichenlaub as Managing Directors, Shashi Jain as Venture Partner, and co-founder Jim Huston as Managing Director Emeritus. Its official portfolio includes Hydrolix, Photon Marine, Caravel Bio, Neurosom, StrateSea and other technology companies. Intrepid is anchored by a $4 million initial Business Oregon investment; that anchor is not asserted to be the vehicle's final fund size. Current portfolio descriptions and clinical claims still require company-level verification.

SK Networks Co., Ltd. is a South Korean listed operating holding company and corporate investor founded as Sunkyong Textiles on April8,1953. Its current business spans ICT distribution and logistics, hotels and resorts, appliance and wellness services, data solutions and AI applications. Its investment strategy seeks future growth in AI, digital transformation and sustainability, linking portfolio companies with operating businesses. The current official global investment page distinguishes direct company investments from commitments to outside venture funds and describes Hicosystem, its founder/investor/adviser network. SK Networks Americas LLC/HICO Capital and HICO Management are separately identified US investment subsidiaries; their specific company subscriptions and managed funds are not automatically direct legal-parent cash. The retained Adex InvestmentFirm profile represents SK Networks’ corporate investor identity, rather than a standalone externally funded VC manager. Its primary January11,2022 announcement confirms participation in LVIS’s announced USD15million SeriesB-2, explicitly distinct from SKInc.’s2018 LVIS investment. Its official seven-person board directory and2026 CEO message identify Hojeong Lee as CEO and president. SKNetworks is distinct from SKInc., SKVentures, SKhynix and other group entities; none is merged or treated as interchangeable. Corporate revenues, investment budgets, fund commitments and acquisition consideration are not LP fund closes.

Philanthropic foundation created by Eric and Wendy Schmidt to support a healthy, resilient and secure world. Foundation identity should remain distinct from separately named investment vehicles.

Unconventional Ventures is a Nordic venture capital firm investing at pre-seed and seed in scalable technology companies across the Nordics and Europe. It backs underrepresented founding teams building businesses with measurable environmental or social impact, with particular interest in climate and the environment, health and femtech, education and financial inclusion. The firm combines investment analysis and impact measurement with founder support on commercial scaling, governance, branding and international expansion. Its Danish legal manager is Unconventional Ventures ApS.

Wonder Ventures is a Los Angeles venture-capital manager backing Southern California founders at pre-seed and subsequent stages. Its exact legal manager is Wonder Ventures Management LLC, CRD173946, SEC exempt-reporting-adviser file802-127719; official fund filings identify it as management company and Dustin Rosen as the general partner’s managing director. It is distinct from unrelated Wonder-branded companies and differently identified investment managers. Relevant portfolio spans AI, biological computing, deep technology and healthcare. The current main directory publishes five professionals, including Taylor Bolhack as advisor rather than head of platform; a separate founder-LP page identifies Abha Nath as venture partner. Founder announcements report USD15M FundII and USD31M FundIII. A 2024 announcement reports USD102M combined across FundIV and the first opportunity fund; the split and exact cash closing days are not independently established and that aggregate is not counted twice. The July9,2026 FundV FormD reports first sale yet to occur and zero sold, so its final amount/date remain NULL. Official indexed ADV identifies a FundIV sidecar; inaccessible full PDF limits the completeness of the legal vehicle inventory. Founder-LP membership is not an employee title or a portfolio-company investment.

pi Ventures is an India-focused early-stage venture capital firm that backs founders building differentiated technologies for global markets. It invests in applied artificial intelligence and deep technology, including advanced computing, quantum technology, robotics, space systems, semiconductor infrastructure, life sciences and materials. The firm evaluates the underlying technical advantage and intellectual property, then supports founders with patient capital, operating knowledge and networks. Its published portfolio includes AI-assisted mental health, breast-cancer screening, pathology, antibody design, industrial inspection and logistics, alongside rockets, energy storage and photonic interconnects. The legal investment manager is Pi Partners LLP, managing Indian Category I venture-capital trusts PI VENTURES INVESTMENT TRUST and PI VENTURES INVESTMENT TRUST II. It is distinct from Greek Big Pi Ventures and the Pi Network ecosystem investment initiative.

Access Venture Partners is a Colorado-based venture capital firm investing in early-stage technology companies, with offices in Westminster and Denver. Its investment themes cover enterprise software and applied AI, cybersecurity and defense technology, technology infrastructure and managed marketplaces. It typically invests at pre-seed through Series A and reserves capital for follow-on support, combining a Mountain West network with a national investment approach. Co-founders Frank Mendicino II and Frank Mendicino III built the firm; its current team lists Managing Partners Kirk Holland, Frank Mendicino III and Brian Wallace, Principals Eric Shu and Alex Houghtalin, and finance and investor-relations staff. Frank Mendicino II is listed as Co-Founder and Emeritus Partner. Access announced a $47 million Fund V in April 2023. It co-led Rapta's $8 million industrial AI financing with Voyager Capital in September 2026. Its public portfolio includes companies such as PlanetiQ, Red Canary, RADICL Defense and Hyperia; individual current status and financing histories require issuer-level verification.

Atinum Investment is a South Korean venture capital firm that backs growth-stage technology businesses internationally. Its investment teams cover artificial intelligence, semiconductors, robotics and mobility, enterprise software and online services, biotechnology and healthcare, and gaming and digital content. The firm supports companies through multiple stages of growth and follow-on financing, and maintains specialist teams for investment management, portfolio support, fund operations, and overseas capital formation. Its portfolio includes industrial and physical AI, medical technology, and platforms that apply advanced software to large commercial markets.

Brandon Capital is the Australian life-sciences venture investment platform of Brandon Capital Partners Pty Ltd, ACN128415903/ABN82128415903, established2007 and based in Melbourne with Sydney and international investment activities. Its own website and legal-registry addresses establish exact identity; the unrelated Brandon Capital Pty Ltd ACN106734392 is excluded. The platform supports biomedical commercialisation from early discovery through clinical development, including therapeutics, medical devices, neuroscience and digital health. It manages Brandon BioCatalyst, formerly the Medical Research Commercialisation Fund, a collaboration of institutional investors, government and more than50 Australian/New Zealand medical research organisations. The collaboration is not a second duplicate company cash buyer. Its published40-person directory comprises partners, investment professionals, CUREator programme staff, corporate services, venture partners and advisers, including an explicitly emeritus partner. Its own footer identifies separately licensed BCP2 PtyLtd AFSL525465 and BCP3 PtyLtd AFSL525467; fund-specific statutory paying affiliates are not guessed. Fund sizes are verified corpus/close snapshots, kept separate from assets-under-management claims, targets, government programme-wide budgets and individual portfolio allocations. The inherited InvestmentFirm type and all historical financing/private identities are preserved.

Ambra Capital is the French AMF-authorised alternative investment manager formerly named Anaxago Capital, RCS Paris840861397, approval GP-18000016, LEI969500M9G8KAHGFMQ388, established in2018. Its strategies include venture capital, impact private equity/fund-of-funds, property private equity, hospitality and private debt. CapHorn Invest continues as its venture-capital brand, supporting early-stage and follow-on investments in healthcare AI, robotics, data technology and climate/deep technology. Primary signed2021 accounts document Anaxago Capital’s acquisition and legal absorption of the distinct former CapHorn Invest company RCS521914382 on December29,2021, with retroactive accounting/tax effect January1,2021 and AMF-approved transfer of managed vehicles. This retained investor profile preserves the historical CapHorn investment graph while documenting its successor manager; management transfer is not new fundraising. The Ambra brand was adopted inDecember2025; January2026 certified statutes and GLEIF confirm the same continuing840861397 legal entity. The separate Anaxago crowdfunding platform SAS539539064 publishes parts of the website and is not this regulated manager. Current Ambra and CapHorn directories are distinguished from qualified legacy Anaxago Capital staff. Nine funds were reported under management at December31,2025; eight exact named vehicles are evidenced across filed accounts and the2025 sustainability report, while the ninth identity remains unpublished in reviewed sources. Reported assets, product targets and predecessor fund transfers are excluded from cash-close amounts. AxClimat’s reported EUR30M already collected is an interim subscription snapshot, not a final close.

Graphene Ventures is a venture-capital firm founded in2015 that invests directly in private technology businesses. Its official site identifies operations in Palo Alto, Toronto, São Paulo and Riyadh and a ten-person public team. Relevant published portfolio includes autonomous airport logistics developer AeroVect, robotics companies, AI businesses and health technology. The exact legal manager is Graphene Ventures LLC (CRD281412); its March31,2025 FormADV reports as an exempt reporting adviser under SEC file802-107098. This is distinct from graphene-materials businesses and Graph Ventures. The firm’s claim of more than twelve funds and over USD250M deployed is an aggregate operating track record, not a verified single-fund final close. Accessible indexed official ADV excerpts identify separate private fund vehicles; actual final fund sizes/days remain unverified, and company investment allocations are not inferred from assets under management. A further live published operations profile identifies Akram Yassin; he is absent from the main team directory and his current tenure is not independently confirmed.

Investment manager for Harvard University’s endowment, investing across multiple asset classes including venture capital and direct investments.

IAG Capital Partners is a venture capital firm investing from seed through Series D. Its portfolio spans AI and data software, next-generation computing, hardware, cybersecurity, life sciences and financial services. The firm leads and participates in startup financing rounds and has offices in Charleston, New York and London.

Investinor is a Norwegian state-backed investment company providing risk capital to businesses with international growth potential and supporting the country’s early-stage investment market. It invests directly alongside private investors, commits capital to seed and venture funds, and makes matching and pre-seed investments. Its active ownership combines financing with commercial expertise, networks and board participation across technology, healthcare, energy, aquaculture and other sectors. Based in Trondheim with an Oslo office, Investinor also administers government interests in seed and pre-seed programs and Northern Norway investment mandates. Its capital-management role includes direct company investments and investment in independently managed funds.

Irregular Expressions (IrregEx) is an early-stage venture investment platform based in New York and San Francisco, backing business-to-developer infrastructure software at pre-seed and seed. Its published focus includes artificial intelligence, data engineering, DevOps, security, observability and developer productivity. Founder and General Partner Jean Sini began an engineering-leader syndicate in 2018 and converted it into a venture fund in 2022. Its portfolio distinguishes Fund I investments from earlier SPV investments. The current public directory lists 99 people: Jean Sini, Principal Vlad Rachev and a community of advisors and limited partners drawn from engineering and product leadership; these community affiliations do not imply 99 salaried employees or general partners. No primary-source fund closing amount or current AUM was verified. IrregEx is distinct from the AI-security company Irregular at irregular.com.

Mundi Ventures invests in technology companies through venture and growth strategies, including insurance technology, retail technology and deep tech. It manages Kembara, a European growth fund that backs AI, computing, robotics, clean energy, materials, space and defense technologies as they scale.

Primavera Capital Group is an Asia-Pacific-based global investment firm founded by Fred Hu in 2010. Its published strategy spans venture and growth equity, private credit, special situations and buyouts, with offices in Hong Kong, Beijing, Singapore and Silicon Valley. The group manages RMB and USD capital and backs businesses in technological innovation, decarbonisation, healthcare and consumer services. Its current public roster identifies twenty-five management and advisory professionals, with explicit AI, industrial technology, medical-equipment and healthcare investment responsibilities. The group directory includes Primavera Venture Partners as a published investment unit, without establishing a separate legal manager record. SEC fund disclosures identify Primavera Capital Management Limited/Ltd as manager or adviser and separately identify statutory general partners; the operating group, legal adviser and funds are qualified rather than conflated. Its own Fund IV announcement confirms a USD4.1B final close in February2023, while earlier offering snapshots and portfolio valuations are not additional closed cash. The retained Primavera Capital alias and its inherited financial and Goldilocks references remain separate pending record-specific legal attribution. ZAP Surgical’s issuer names this exact group as leader of its completed USD81M January2020 financing; no personal partner allocation is inferred.

Proximity Ventures is a New York multi-stage venture investment firm. Its own company profile identifies Neil Sirni and Olivia Wilde as co-founders and gives a 2023 founding year; Sirni identifies himself as co-founder and general partner. Primary SEC filings identify Proximity Ventures Management Co., LLC as the managing member of the managing members of Delaware vehicles Proximity Health I, LLC and Proximity Fifth Down I, LLC, with Neil Sirni the individual managing member. These fund vehicles are separate from the management company and underlying portfolio companies. The existing investor record previously labeled Proximity Capital is retained because its Delphi AI investment source explicitly names Proximity Ventures, with Olivia Wilde and Santigold. The Italian Proximity Capital, African Proximity Ventures, Proximity Lab design studio and General Proximity biotechnology company are distinct and are not merged. Delphi is a primary-confirmed AI portfolio investment. The Biological Computing Company financing announcement names only Proximity without a domain or representative; that possible relationship remains unassigned pending a direct primary identity bridge. The public firm website currently publishes its name without a complete team directory or accessible authentic logo. Own profiles also establish Jason Mack affiliation and Steve Francis investing at the firm; Delphi names Santigold as an investment representative, without publishing her formal manager title. Current completeness and role titles are qualified accordingly. The 2024 SEC notices report no first sale and zero capital sold for Health I and Fifth Down I; their USD5M and USD10M offering limits are fundraising targets, not actual fund closes. No firm AUM, target size, predecessor Arrive portfolio or personal celebrity investment is treated as company cash.